Previous reports have demonstrated that the chemerin receptor CCRL2 upregulation contributes to glioblastoma cell migration [27], cutaneous squamous cell carcinoma [28], and acute myeloid leukemia [29]. This evidence concerns the gene CMKLR1 and cutaneous squamous cell carcinoma.